We are pleased to bring you the latest edition of the MID-Frail newsletter [1]. You may notice, we have refreshed the newsletter design to make it more modern and approachable. We hope that you like it. Why not tell us what you think?

A lot of changes have taken place on the “MID-Frail team”. We have a new Clinical Project Manager, María Ángeles Martín from Fundación para la Investigación Biomédica del Hospital Universitario de Getafe, and a new Communications Project Manager, Severina Moreira, from the Niche team. Also new to the team is Mike Howkins who will be providing guidance on pharmacovigilance.

Read-on to see the latest news and updates on our study. The MID-Frail study is progressing at a good pace with site selection being complete in Belgium, the Czech Republic, Germany, Italy, France-Bordeaux and the United Kingdom. Latest updates can be found on the website [2].

Spain appears to be leading the way with all trial sites selected and ethics approval being confirmed for every site. A third version of the protocol was submitted as an amendment in March this year. An Investigators’ meeting took place on June 20th at the Hospital Universitario de Getafe in Madrid. Professor Mikel Izquierdo explained in detail the exercise program described in the study protocol and made a demonstration with the machines that will be used.

A manuscript describing the study protocol has been submitted to the journal ‘Trials’ and is being considered for publication. We believe that this manuscript will help to raise the profile of MID-Frail and will be an important reference to be included in future publications.

References

1. MID-Frail consortium newsletter #4
2. www.midfrail‐study.org